drugset / Trial / NCT06806826
The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study
RandomizedParallel-groupOpen-labelTreatment
Summary
We aimed to evaluate the usability and efficacy of omalizumab in allergic rhinitis and its potential as an alternative treatment option.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omalizumab | Monoclonal antibody | 300 mg | Subcutaneous |